Literature DB >> 15730530

Proteomic identification of the involvement of the mitochondrial rieske protein in epilepsy.

Heike Junker1, Kira Späte, Yalikun Suofu, Reinhard Walther, Gerold Schwarz, Winfried Kammer, Alfred Nordheim, Lary C Walker, Uwe Runge, Christof Kessler, Aurel Popa-Wagner.   

Abstract

PURPOSE: Kindled seizures are widely used to model epileptogenesis, but the molecular mechanisms underlying the attainment of kindling status are largely unknown. Recently we showed that achievement of kindling status in the Sprague-Dawley rat is associated with a critical developmental interval of 25 +/- 1 days; the identification of this long, well-defined developmental interval for inducing kindling status makes possible a dissection of the cellular and genetic events underlying this phenomenon and its relation to normal and pathologic brain function.
METHODS: By using proteomics on cerebral tissue from our new rat kindling model, we undertook a global analysis of protein expression in kindled animals. Some of the identified proteins were further investigated by using immunohistochemistry.
RESULTS: We report the identification of a modified variant of the Rieske iron-sulfur protein, a component of the mitochondrial cytochrome bc1 complex, whose isoelectric point is shifted toward more alkaline values in the hippocampus of kindled rats. By immunohistochemistry, the Rieske protein is well expressed in the hippocampus, except in the CA1 subfield, an area of selective vulnerability to seizures in humans and animal models. We also noted an asymmetric, selective expression of the Rieske protein in the subgranular neurons of the dorsal dentate gyrus, a region implicated in neurogenesis.
CONCLUSIONS: These results indicate that the Rieske protein may play a role in the response of neurons to seizure activity and could give important new insights into the molecular pathogenesis of epilepsy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15730530     DOI: 10.1111/j.0013-9580.2005.46904.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  4 in total

1.  Proteomic profiling of the epileptic dentate gyrus.

Authors:  Aiqing Li; Yun-Sik Choi; Heather Dziema; Ruifeng Cao; Hee-Yeon Cho; Yeon Joo Jung; Karl Obrietan
Journal:  Brain Pathol       Date:  2010-07-04       Impact factor: 6.508

2.  Repeated PTZ treatment at 25-day intervals leads to a highly efficient accumulation of doublecortin in the dorsal hippocampus of rats.

Authors:  Ana-Maria Buga; Raluca Vintilescu; Adrian Tudor Balseanu; Oltin Tiberiu Pop; Costin Streba; Emil Toescu; Aurel Popa-Wagner
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

Review 3.  Neuroproteomics in Epilepsy: What Do We Know so Far?

Authors:  Amanda M do Canto; Amanda Donatti; Jaqueline C Geraldis; Alexandre B Godoi; Douglas C da Rosa; Iscia Lopes-Cendes
Journal:  Front Mol Neurosci       Date:  2021-01-07       Impact factor: 5.639

4.  The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stress.

Authors:  Boštjan Martinc; Iztok Grabnar; Tomaž Vovk
Journal:  Curr Neuropharmacol       Date:  2012-12       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.